皮质类固醇抵抗的分子机制。 - Suppr | 超能文献

Molecular mechanisms of corticosteroid resistance.

作者信息

Tonello Antonella, Poli Giovanni

机构信息

Mater Salutis Hospital, Legnago, Italy.

Ospedale Policlinico G. B. Rossi, Verona, Italy.

出版信息

Chest. 2009 Feb;135(2):585-586. doi: 10.1378/chest.08-2385.

DOI:10.1378/chest.08-2385

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Molecular mechanisms of corticosteroid resistance.皮质类固醇抵抗的分子机制。

Chest. 2009 Feb;135(2):585-586. doi: 10.1378/chest.08-2385.

2

Corticosteroid resistance in airway disease.气道疾病中的皮质类固醇抵抗

Proc Am Thorac Soc. 2004;1(3):264-8. doi: 10.1513/pats.200402-014MS.

3

Restoration of Corticosteroid Sensitivity in Chronic Obstructive Pulmonary Disease by Inhibition of Mammalian Target of Rapamycin.通过抑制雷帕霉素哺乳动物靶点恢复慢性阻塞性肺疾病中的皮质类固醇敏感性

Am J Respir Crit Care Med. 2016 Jan 15;193(2):143-53. doi: 10.1164/rccm.201503-0593OC.

4

Corticosteroids: the drugs to beat.皮质类固醇：战胜疾病的药物。

Eur J Pharmacol. 2006 Mar 8;533(1-3):2-14. doi: 10.1016/j.ejphar.2005.12.052. Epub 2006 Jan 24.

5

Rethinking chronic obstructive pulmonary disease.重新思考慢性阻塞性肺疾病。

Med Hypotheses. 2011 Mar;76(3):358-60. doi: 10.1016/j.mehy.2010.10.039. Epub 2010 Nov 13.

6

Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy.哮喘和慢性阻塞性肺疾病中的氧化应激与类固醇抵抗：以HDAC-2的药物调控作为治疗策略

Expert Opin Ther Targets. 2007 Jun;11(6):745-55. doi: 10.1517/14728222.11.6.745.

7

Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.慢性阻塞性肺疾病中的皮质类固醇抵抗：组蛋白去乙酰化酶的失活

Lancet. 2004 Feb 28;363(9410):731-3. doi: 10.1016/S0140-6736(04)15650-X.

8

Molecular mechanisms of corticosteroid resistance.皮质类固醇抵抗的分子机制。

Chest. 2008 Aug;134(2):394-401. doi: 10.1378/chest.08-0440.

9

Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease.哮喘和慢性阻塞性肺疾病患者的皮质类固醇抵抗。

J Allergy Clin Immunol. 2013 Mar;131(3):636-45. doi: 10.1016/j.jaci.2012.12.1564. Epub 2013 Jan 26.

10

Pharmacogenomics and outcome of asthma: no clinical application for long-term steroid effects by CRHR1 polymorphisms.药物基因组学与哮喘的预后：CRHR1基因多态性对长期类固醇效应无临床应用价值。

J Allergy Clin Immunol. 2008 Jun;121(6):1510-3. doi: 10.1016/j.jaci.2008.04.015.

引用本文的文献

1

Long Noncoding RNAs in the Regulation of Asthma: Current Research and Clinical Implications.长链非编码RNA在哮喘调控中的研究现状与临床意义

Front Pharmacol. 2020 Sep 11;11:532849. doi: 10.3389/fphar.2020.532849. eCollection 2020.